EUVIMEDEUVIMED entdecken
Studienprotokoll

L26/O-139 Does stimulation protocol determine optimal trigger strategy? A multicenter RCT comparing sequential double versus simultaneous dual trigger in POSEIDON group 3-4 poor ovarian responders

P. Parhar, D. Rao, B. Reddy, M. Narasimman

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.139 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von P. Parhar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does sequential double trigger outperform simultaneous dual trigger in POSEIDON group 3-4 poor responders, and does optimal strategy differ by stimulation protocol? Summary answer Sequential double trigger significantly improved oocyte yield (+26%) and fertilization (+32%) in PPOS but not antagonist cycles - first RCT evidence for protocol-specific trigger optimization. What is known already Both dual trigger (simultaneous GnRH agonist + hCG) and double trigger (sequential administration with 4-6hour interval) improve final oocyte maturation compared to hCG alone in poor responders. Meta-analyses support both approaches, yet no randomized trial has directly compared them. Furthermore, whether the optimal trigger strategy differs between stimulation protocols used in expected poor responders—particularly progestin-primed ovarian stimulation (PPOS) versus GnRH antagonist—remains unknown. This question has important clinical implications as PPOS is increasingly adopted for poor responders due to scheduling flexibility and cost-effectiveness. Study design, size, duration Multicenter, randomized controlled trial conducted at 4 centers in Hyderabad, India from December 2024 to December 2025. 179 POSEIDON group 3-4 patients were randomized 1:1 to sequential double trigger (n = 89) or simultaneous dual trigger (n = 90). Pre-specified subgroup analysis by stimulation protocol included PPOS (n = 110: 55 vs 55) and GnRH antagonist (n = 69: 34 vs 35) cohorts. Block randomization was stratified by center, POSEIDON group (3 vs 4), and stimulation protocol.

Trial registration

CTRI/2025/10/096009. Participants/materials, setting, methods Inclusion: Women aged 21-42 years, POSEIDON group 3 -4 (AFC <5, AMH <1.2 ng/mL) undergoing IVF/ICSI with PPOS or GnRH antagonist protocol.

Interventions

Double trigger (triptorelin 0.2mg at 38-40hours + hCG 5000 IU at 34-35hours, sequential ) versus dual trigger (triptorelin 0.2mg + hCG 5000 IU simultaneously at 35hours). Outcomes: Primary: oocytes retrieved. Secondary: MII oocytes, fertilization, blastocysts, top quality embryos (TQE). Pre-specified subgroup analysis by stimulation protocol. Statistics: ITT analysis. Mann-Whitney U, Fisher’s exact, p < 0.05. Main results and the role of chance Baseline: Groups were well-balanced for age (33.3±5.5 vs 33.4±4.5y, p = 0.89), AMH (0.70±0.35 vs 0.70±0.47 ng/mL, p = 0.85), and gonadotropin dose (3554±1176 vs 3503±1026 IU, p = 0.95). Protocol distribution was identical (PPOS 62% vs 61%, p = 1.00). Overall cohort (n = 179): No significant differences in oocytes retrieved (7.01±4.30 vs 6.20±4.82, p = 0.093) or other outcomes, though numerical trends favored double trigger. Pre-specified PPOS subgroup (n = 110): Double trigger showed significantly higher oocytes retrieved (7.53±4.04 vs 5.98±4.68, p = 0.018, d = 0.35) and fertilized oocytes (4.87±3.00 vs 3.69±2.77, p = 0.028, d = 0.41). MII oocytes trended higher (5.51±3.41 vs 4.36±3.04, p = 0.081). TQE was similar (1.05±1.53 vs 0.95±1.34, p = 0.96). Pre-specified antagonist subgroup (n = 69): No significant differences in any outcome (oocytes: 6.18±4.63 vs 6.54±5.08, p = 0.74; fertilized: 3.79±3.47 vs 3.74±3.09, p = 0.86). Safety: Zero premature ovulations in either group (0%). Limitations, reasons for caution Study was powered for the overall comparison; subgroup analyses were pre- specified but the antagonist cohort (n = 69) may be underpowered for smaller effects. Clinical pregnancy and live birth outcomes were not assessed. The biological mechanism underlying the differential response between PPOS and antagonist protocols warrants further investigation. Wider implications of the findings This first head-to-head RCT demonstrates protocol-dependent trigger optimization in poor responders. Clinicians using PPOS protocol should preferentially employ sequential double trigger for superior outcomes; antagonist protocol users may choose either strategy. These findings support precision medicine- individualizing trigger selection based on stimulation protocol in challenging patient populations. Trial registration number Yes

Zitieren

APA

Parhar, P., Rao, D., Reddy, B., & Narasimman, M. (2026). L26/O-139 Does stimulation protocol determine optimal trigger strategy? A multicenter RCT comparing sequential double versus simultaneous dual trigger in POSEIDON group 3-4 poor ovarian responders. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.139

Vancouver

Parhar P, Rao D, Reddy B, Narasimman M. L26/O-139 Does stimulation protocol determine optimal trigger strategy? A multicenter RCT comparing sequential double versus simultaneous dual trigger in POSEIDON group 3-4 poor ovarian responders. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.139

BibTeX
@article{Parhar2026,
  author = {Parhar, P. and Rao, D. and Reddy, B. and Narasimman, M.},
  title = {L26/O-139 Does stimulation protocol determine optimal trigger strategy? A multicenter RCT comparing sequential double versus simultaneous dual trigger in POSEIDON group 3-4 poor ovarian responders},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.139}
}
Kostenlos starten →